-
Mashup Score: 2The Role of Artificial Intelligence in Early Cancer Detection: Exploring Early Clinical Applications | AI in Precision Oncology - 16 day(s) ago
Introduction: Early cancer detection can lead to improved outcomes and a shift toward a prevention model. This review explores the role of artificial intelligence (AI) in early cancer detection, focusing on its application in various clinical settings. Methods: A literature search was conducted using databases such as PubMed, Scopus, Web of Science, and IEEE Xplore, focusing on studies that applied AI in early cancer detection. The search, covering articles up to November 2023, included studies discussing clinical applications and trials. The findings were categorizing studies based on AI techniques, cancer types, and clinical application stages. Results: AI in oncology, particularly machine learning (ML) and deep learning, has shown promise in enhancing early cancer detection, including breast, lung, prostate, skin, gastrointestinal, and other cancers. These technologies have been applied to various data types, including electronic health records, medical imaging, and biomarkers such
Source: www.liebertpub.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer - 1 month(s) ago
PURPOSE Current guidelines for the management of metastatic non–small cell lung cancer (NSCLC) without driver mutations recommend checkpoint immunotherapy with PD-1/PD-L1 inhibitors, either alone or in combination with chemotherapy. This approach fails to account for individual patient variability and host immune factors and often results in less-than-ideal outcomes. To address the limitations of the current guidelines, we developed and subsequently blindly validated a machine learning algorithm using pretreatment plasma proteomic profiles for personalized treatment decisions. PATIENTS AND METHODS We conducted a multicenter observational trial (ClinicalTrials.gov identifier: NCT04056247) of patients undergoing PD-1/PD-L1 inhibitor–based therapy (n = 540) and an additional patient cohort receiving chemotherapy (n = 85) who consented to pretreatment plasma and clinical data collection. Plasma proteome profiling was performed using SomaScan Assay v4.1. RESULTS Our test demonstrates a stro
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Exciting to be part of a talented multi-disciplinary team to advance the cause for patients with lung cancer https://t.co/gE1uVeoIu5 @KimmelCancerCtr @TJUHospital @drgandara @NCIDirector
-
-
Mashup Score: 0YM Careers Maintenance - 1 month(s) ago
YourMembership.com provides affordable association management software solutions. Our membership software will help connect your organization’s member base — all association management software features, hosting, future upgrades and client service are included for one low annual fee. And we will have you up and running quickly!
Source: maintenance.careerwebsite.comCategories: General Medicine News, Hem/OncsTweet-
We have a new faculty position https://t.co/eQgRltYSGY
-
-
Mashup Score: 2Frontiers | Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy - 2 month(s) ago
Introduction Immune checkpoint inhibitors have made a paradigm shift in the treatment of non-small cell lung cancer (NSCLC). However, c…
Source: www.frontiersin.orgCategories: General Medicine News, Hem/OncsTweet-
A privilege to be part of this international study, highlighting the potential of plasma proteomics to identify mechanisms of therapy resistance and biomarkers #lungcancer @KimmelCancerCtr @TJUHospital https://t.co/s9PPOA0b2G https://t.co/DyvLCfrBTI
-
-
Mashup Score: 3
Posted 4:35:27 AM. Thomas Jefferson University seeks a visionary and collaborative academic physician leader to serve…See this and similar jobs on LinkedIn.
Source: www.linkedin.comCategories: General Medicine News, Hem/OncsTweet-
We are looking for great people: Chair of the Department of Radiology at Thomas Jefferson University & at Jefferson Health @JeffersonUniv @JeffersonUniv @KimmelCancerCtr https://t.co/1SdXRKZ2NH
-
-
Mashup Score: 0Jefferson Breast Surgeon Selected for Second Cohort of Robert A. Winn Career Development Award - 7 month(s) ago
The Bristol Myers Squibb Foundation established the Robert A. Winn Career Development Award (CDA) to increase diversity in clinical trials and transform the clinical research landscape. The program aims to improve representation among two key populations: patients participating in trials as well as the clinicians and scientists leading clinical trials. Assistant Professor of Surgery Adeseye Adekeye, MD, PhD, is one of 64 early-stage investigators selected for the second cohort of the Winn CDA program. The program funds $120,000 a year for two years, with the awardees spending at least 40% of their time on the program. Dr. Adekeye and the other awardees participate in biweekly education and Jefferson Breast Surgeon Selected for Second Cohort of Robert A. Winn Career Development Award training sessions. So far, the meetings have covered the history of clinical trials, a variety of topics related to diversity in clinical trials, design of clinical trials, and different tools to support re
Source: jdc.jefferson.eduCategories: Hem/Oncs, Latest HeadlinesTweet-
Kudos to @NickiSimone4 for her mentorship for surgeons receiving the Robert A. Winn Career Development Award https://t.co/R8c60u5gKR @KimmelCancerCtr @ASTRO_org @ASCO @AACR @bmsnews
-
-
Mashup Score: 0Thoracic Radiation Oncologist Job Opening in Philadelphia, Pennsylvania - American Society for Radiation Oncology - 7 month(s) ago
A new Thoracic Radiation Oncologist job is available in Philadelphia, Pennsylvania. Check it out on American Society for Radiation Oncology.
Source: careers.astro.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
We are looking for a Thoracic Radiation Oncologist to join a fantastic team https://t.co/eQgRltYSGY -If you plan to be at @ASTRO_org #ASTRO23 @ACROresident please DM me
-
-
Mashup Score: 0Evaluation of variables predicting PFT changes for lung cancer patients treated on a prospective 4DCT-ventilation functional avoidance clinical trial - 9 month(s) ago
Functional avoidance radiotherapy uses functional imaging to reduce pulmonary toxicity by designing radiotherapy plans that reduce doses to functional…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Congratulations to our fabulous team! - Study evaluated which metrics are predictive of PFT changes for lung cancer patients treated with 4DCT-ventilation functional avoidance https://t.co/g8zguVX1Qd @TJUHospital @KimmelCancerCtr @aapmHQ @ASTRO_org
-
-
Mashup Score: 0Cancer Doctors Rethink Aggressive Treatments - 11 month(s) ago
Cervical and rectal cancer patients responded as well to less invasive care, studies show.
Source: WSJCategories: Hem/Oncs, Latest HeadlinesTweet-
This @WSJhealth @WSJ article captured a great deal of excitment @ASCO #ASCO23 https://t.co/sZJFHMGCUI We are proud of the efforts on many people at @KimmelCancerCtr working towards this goal
-
-
Mashup Score: 0Avoid false proxies - 11 month(s) ago
They’re toxic, wasteful and a tempting trap. It’s one of the most important topics in my new book. (And here’s a new podcast on it). We need proxies. You’re not allowed to r…
Source: Seth's BlogCategories: Hem/Oncs, Latest HeadlinesTweet-
A helpful approach way to frame cognitive bias and superficial qualities that may blind us @SethGodinBlog Avoid false proxies https://t.co/UxHnRDJEp0
-
A pleasure to be part of this great team effort on AI led by @NGThaker_XRT in #AI early cancer detection @KimmelCancerCtr @TJUHospital https://t.co/oHTBUPyz5K